Nasal-type extranodal natural killer/T-cell lymphoma presenting as multiple cutaneous masses. 2023

Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
Department of Dermatology, KCU-GME Advanced Dermatology and Cosmetic Surgery, Oviedo, FL, USA.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009669 Nose Neoplasms Tumors or cancer of the NOSE. Cancer of Nose,Nasal Neoplasms,Nose Cancer,Cancer of the Nose,Nasal Cancer,Neoplasms, Nose,Cancer, Nasal,Cancer, Nose,Cancers, Nasal,Cancers, Nose,Nasal Cancers,Nasal Neoplasm,Neoplasm, Nasal,Neoplasm, Nose,Neoplasms, Nasal,Nose Cancers,Nose Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016399 Lymphoma, T-Cell A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. T-Cell Lymphoma,Lymphoma, T Cell,Lymphomas, T-Cell,T Cell Lymphoma,T-Cell Lymphomas
D054391 Lymphoma, Extranodal NK-T-Cell An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites. Extranodal NK-T-Cell Lymphoma,Extranodal NK-T-Cell Lymphoma, Nasal,Extranodal NK-T-Cell Lymphoma, Nasal Type,Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type,Extranodal NK T Cell Lymphoma,Extranodal NK T Cell Lymphoma, Nasal,Extranodal NK T Cell Lymphoma, Nasal Type,Extranodal NK T Cell Lymphoma, Nasal and Nasal Type,Extranodal NK-T-Cell Lymphomas,Lymphoma, Extranodal NK T Cell,Lymphomas, Extranodal NK-T-Cell,NK-T-Cell Lymphoma, Extranodal,NK-T-Cell Lymphomas, Extranodal

Related Publications

Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
October 2012, Journal of the American Academy of Dermatology,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
January 2017, Indian journal of dermatology, venereology and leprology,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
January 2010, Advances in hematology,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
May 2008, Actas dermo-sifiliograficas,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
January 2022, Proceedings (Baylor University. Medical Center),
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
January 2010, Skinmed,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
September 2017, Actas dermo-sifiliograficas,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
February 2010, The American Journal of dermatopathology,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
January 2018, Indian journal of dermatology, venereology and leprology,
Austin Ambur, and Michael Foss, and Jason Mammino, and Sadia Saeed, and Charles Dunn, and Aashni Bhukhan, and Rajiv Nathoo
June 2015, Cornea,
Copied contents to your clipboard!